Skip to main content

Search website

AIDS Education and Training Centers National Coordinating Resource Center (AETC NCRC)

Training
Consultation
Directory
Library
Calendar
Community
Home

Home / Library / From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation

From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation

Publish date: October 19, 2016

AETC source: Southeast AETC

Link to File & Online Module

Objectives

Describe the financial impact of HCV treatment
Identify current restrictions to HCV treatment common among third party payers
Illustrate successful navigation through the prior authorization and appeal process
Review criteria and options for patient assistance programs (PAP)

Speaker

Autumn Bagwell PharmD BCPS

Was this page helpful? *

Yes

No

I found this page helpful because the content on the page:

Check all that apply

Had the information I needed

Was trustworthy

Was up-to-date

Was written clearly

I did not find this page helpful because the content on the page:

Check all that apply

Had too little information

Had too much information

Was confusing

Was out-of-date

Other reason or comment

Other reason or comment

Leave this field blank

Browse more

Language: English

Topic(s): Clinical Program Management, Comorbidities, Coinfections, & Complications, Viral Hepatitis Coinfection

Resource type: Online and Self-Paced Learning

Add comment

Log in to post comments

Library Home
Topic Index
News Watch
Clinical Reference Tools
Guidelines
Online and Self-Paced Learning
Training Materials
Web Links
Resource Order Form

About
Contact
Subscribe
Policies
Log In

Keep in Touch

Facebook
Twitter
YouTube
Linked In
Pinterest

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Centers National Coordinating Resource Center) awarded to the François-Xavier Bagnoud Center, Rutgers University School of Nursing. No percentage of this project was financed with non-governmental sources. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.